Next Century Growth Investors LLC Buys 138,915 Shares of Alphatec Holdings, Inc. $ATEC

Next Century Growth Investors LLC grew its holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC) by 6.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,418,298 shares of the medical technology company’s stock after purchasing an additional 138,915 shares during the period. Alphatec comprises approximately 3.5% of Next Century Growth Investors LLC’s investment portfolio, making the stock its 2nd biggest holding. Next Century Growth Investors LLC owned approximately 1.63% of Alphatec worth $50,881,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Aster Capital Management DIFC Ltd acquired a new stake in shares of Alphatec in the third quarter valued at approximately $34,000. Osterweis Capital Management Inc. acquired a new stake in shares of Alphatec in the second quarter valued at approximately $37,000. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Alphatec by 157.1% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,571 shares of the medical technology company’s stock valued at $54,000 after purchasing an additional 1,571 shares during the last quarter. China Universal Asset Management Co. Ltd. acquired a new stake in shares of Alphatec in the third quarter valued at approximately $73,000. Finally, FNY Investment Advisers LLC acquired a new stake in shares of Alphatec in the third quarter valued at approximately $74,000. 66.35% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Alphatec

In related news, Director Karen K. Mcginnis sold 6,050 shares of the firm’s stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $8.01, for a total value of $48,460.50. Following the completion of the transaction, the director directly owned 94,671 shares of the company’s stock, valued at approximately $758,314.71. This trade represents a 6.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 13.48% of the company’s stock.

Alphatec Price Performance

NASDAQ:ATEC opened at $8.28 on Friday. Alphatec Holdings, Inc. has a 1-year low of $6.82 and a 1-year high of $23.29. The company has a current ratio of 1.90, a quick ratio of 1.12 and a debt-to-equity ratio of 40.35. The firm has a fifty day simple moving average of $9.12 and a 200 day simple moving average of $13.94. The stock has a market capitalization of $1.27 billion, a PE ratio of -10.10 and a beta of 0.88.

Wall Street Analysts Forecast Growth

ATEC has been the topic of a number of recent research reports. HC Wainwright reiterated a “buy” rating and issued a $24.00 price objective on shares of Alphatec in a report on Thursday, May 7th. JPMorgan Chase & Co. lowered their price objective on shares of Alphatec from $24.00 to $16.00 and set an “overweight” rating on the stock in a report on Wednesday, May 6th. Piper Sandler reiterated an “overweight” rating and issued a $14.00 price objective (down from $25.00) on shares of Alphatec in a report on Wednesday, May 6th. Needham & Company LLC lowered their price objective on shares of Alphatec from $25.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday, May 6th. Finally, Wells Fargo & Company lowered their price objective on shares of Alphatec from $28.00 to $14.00 and set an “overweight” rating on the stock in a report on Thursday, May 7th. Ten equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $18.58.

About Alphatec

Alphatec Holdings, Inc (NASDAQ: ATEC) is a medical technology company focused on the design, development and commercialization of products for the surgical correction of degenerative spinal conditions. The company’s portfolio centers on interbody implants, biologics, fixation devices and surgical planning tools intended to improve patient outcomes in spinal fusion procedures. Alphatec’s flagship offerings include customizable interbody cages, bone graft materials and specialized instrumentation designed for minimally invasive and open spinal surgeries.

Founded as Alphatec Spine in 1985 and rebranded as Alphatec Holdings in 2018, the company has grown from a single-product organization into a multi-platform innovator in the spine market.